Financials

News Discussions Technicals Forecast Seasonals

1558 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. engages in the development, manufacturing, and selling of pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic diseases, cardiovascular diseases, and others. Its products include Benzbromarone, Telmisartan, Amlodipine Besylate, and Cetirizine Hydrochloride. The company was founded on August 8, 2001 and is headquartered in Yichang, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

1558 does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company